Open Access Pre-publication history

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

Jun Guo*, Yiran Huang, Xu Zhang, Fangjian Zhou, Yinghao Sun, Shukui Qin, Zhangqun Ye, Hui Wang, Annette Jappe, Patrick Straub, Nicoletta Pirotta and Sven Gogov

BMC Cancer 2013, 13:136  doi:10.1186/1471-2407-13-136

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 18 Sep 2012
Resubmission - Version 2 Manuscript Author's comment 26 Sep 2012
Reviewer's Report Brian Rini 26 Nov 2012
Reviewer's Report Ronald Bukowski 10 Dec 2012
Reviewer's Report Ronald Bukowski 10 Dec 2012
Resubmission - Version 3 Manuscript Author's comment 18 Jan 2013
Editorial acceptance 11 Mar 2013
Published 21 Mar 2013